Search
Partnering in Biotherapeutics MAY 2023 Corp
Partnering in Biotherapeutics JUNE 2023 CORP
Prevalence of VTE in the US and Europe.pdf
Partnering Day France Flyer Save the date 2018 08 02.pdf
How AF affects the heart.pdf
The Economic Burden of VTE.pdf
The Global Cardiovascular Disease Burden.pdf
The Global Cardiovascular Disease Burden.pdf
The Economic Burden of VTE.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf
add-on_therapy_Moroni-Zentgraf.pdf
Partnership to Develop Urea Cycle Disorders Therapy
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
Lady, a guide dog in the office
A great partnership between a Boehringer Ingelheim employee and her guide dog at work. Their relationship goes beyond the human-animal bond.
Catherine Alonzo
Catherine Alonzo, Patient Safety Physician, Metabolism, tells us about the importance of drug surveillance.
Heidelberg Transforming Science Day 2025 - Save the Date
The Heidelberg Transforming Science Day profiles what makes our innovation different including our ground-breaking research and our diverse pipeline.
Combination Therapy
It’s the smart combination of our cancer cell-directed and immuno-oncology approaches that may offer the greatest benefit for people living with cancer.
Meet the BD&L Team 2019
Hear from our team and find out more about our approach to partnering.
It's about time we better understood the burden of serious mental illness
Ivan Blanarik Therapeutic Area Head Respiratory
Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
CT-155: Prescription digital therapeutic
CT-155: Prescription digital therapeutic